SCHEMBL30565264

SCHEMBL30565264

CCOC(=O)C(CC(C)C)C(=O)Nc1cccc(CN=[N+]=[N-])c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.52
▸ TP53 P04637 1/20 0.52
▸ NPY1R P25929 1/20 0.41
▸ NPY2R P49146 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ USP2 O75604 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MMP8 P22894 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ F7 P08709 1/20 0.37
▸ F3 P13726 1/20 0.37
▸ CTSB P07858 1/20 0.36
▸ CAPN1 P07384 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25383958 0.87 NPY1R (0.44) ALDH1A1TP53NPY1RNPY2RCA12
Hydrochloric Acid SCHEMBL31592556 0.81 ALDH1A1 (0.57) ALDH1A1TP53NPY1RNPY2RCA12
Hydrochloric Acid SCHEMBL25382295 0.81 ALDH1A1 (0.57) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL25384351 0.78 NPY1R (0.43) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL25471075 0.77 ALDH1A1 (0.57) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL25382351 0.77 NPY1R (0.64) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL30565289 0.76 ALDH1A1 (0.50) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL25383545 0.76 ALDH1A1 (0.50) ALDH1A1TP53NPY1RNPY2RCA12
SCHEMBL28945868 0.75 MAPT (0.42) ALDH1A1MAPTNPSR1NPC1RAB9A
SCHEMBL25372310 0.74 MAPT (0.51) ALDH1A1TP53NPY1RNPY2RCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250170104-A1 INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-05-29 — — US disclosed
EP-4486452-A1 INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LASSS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2025-01-08 — — EP disclosed
WO-2023166039-A1 INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-09-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250170104-A1 INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß LTA, SERPINB1, LAS1L ALDH1A1 3061/4885TP53 1612/4885NPY1R 2653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback